ArticleERJ open research2026
Association of PiSlope with lung function decline in individuals with preserved spirometry: a prospective cohort study.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Airway remodelling precedes airflow obstruction in COPD. Pi10 assumes a consistent fixed slope between airway wall thickness and lumen perimeter across individuals. PiSlope comprehensively quantifies airway wall thickening, which is associated with increased acute exacerbation and mortality risk. Whether PiSlope is associated with respiratory prognosis in participants with preserved spirometry is unknown. Methods: Participants with preserved spirometry with complete baseline questionnaires, spirometry and chest computed tomography were enrolled from a 3-year prospective Early Chronic Obstructive Pulmonary Disease (ECOPD) cohort study and divided into four groups by PiSlope quartile (Q) (Q1: PiSlope ≥0.4946, Q2: 0.4550≤ PiSlope <0.4946, Q3: 0.4149≤ PiSlope <0.4550, Q4: PiSlope <0.4149). Clinical outcomes included lung function decline and risk of airflow obstruction progression. Results: 1140 participants with preserved spirometry were included and 1067 (93.6%) completed at least one follow-up lung function assessment. One standard deviation decrease in PiSlope was associated with accelerated decline in pre-bronchodilator forced expiratory volume in 1 s (FEV Conclusion: Lower PiSlope was associated with faster lung function decline and increased airflow obstruction risk in participants with preserved spirometry, but the association between PiSlope and progression to airflow obstruction was not significant after adjustment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.